Related Experiment Video
Updated: Mar 12, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Atypical ulcers in the inpatient setting evaluated by special consult services
Jason R Hernandez1, Kyaw Zin Htet2, Jade N Young1
1Oregon Health & Science University School of Medicine, Portland, Oregon, US.
Objective:
The majority of ulcers in the inpatient setting are pressure-induced or diabetic. As such, research on inpatient ulcers often focuses on these aetiologies. In this study, the authors aim to present the characteristics of patients with atypical cutaneous ulcers (such as, inflammatory, neoplastic, vascular, infectious, drug induced or multifactorial) in the inpatient setting, or non-diabetic, non-pressure ulcers, that require consultation by a specialty service.
Method:
This is a retrospective review of patients at Oregon Health & Science University who underwent formal consultation for a cutaneous ulcer between October 2015 and November 2020. Patients were identified from vascular surgery, plastic surgery, infectious disease and dermatology consultation databases.
Results:
Of the 322 identified patients, 120 were included in the review. The mean patient age at the time of specialty service consultation was 52.46±14.29 years; 54.2% were female (n=65), 8.3% were homeless (n=10) and the majority of patients (n=114, 95.0%) had at least one comorbidity. The most common final diagnoses of ulcer aetiology were: multifactorial (n=36; 30.0%); infectious (n=28, 23.3%); and inflammatory (n=21; 17.5%). Of the patients, 22 (18.3%) were deceased by the time of this retrospective review.
Conclusion:
Patients with atypical ulcers often have comorbid conditions and increased risk of mortality, and may require complex, multispecialty care. Further prospective research evaluating factors that predispose patients to increased morbidity and mortality for these ulcers is indicated.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.